Article
Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease.
European heart journal - 14 Jun 2015
Ross Stephanie, Gerstein Hertzel C, Eikelboom John, Anand Sonia S, Yusuf Salim, Paré Guillaume
Abstract excerpt
INTRODUCTION: Type 2 diabetes is a strong risk factor for coronary artery disease (CAD). However, the absence of a clear reduction in CAD by intensive glucose lowering in randomized controlled trials has fuelled uncertainty regarding the causal role of dysglycaemia and CAD. OBJECTIVE: To assess whether Mendelian randomization supports a causal role of dysglycaemia and diabetes for risk of CAD. METHODS: Effect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
